德国,糖尿病市场报告,美国政府报告.pdfVIP

Germany: Diabetes Market Page 1 of 5 SUMM Germany: Diabetes Market ARY Anette Salama September 2010 Summary Worldwide diabetes is becoming a serious problem. With obesity, and other health problems becoming much more common in society, diabetes is affecting an increasing number of people. There are approximately 246 million diabetic people worldwide, with around 50 million in Europe; 3.6 million died due to diabetes-related complications in Europe in 2007. Germany ranks number six worldwide in the number of diabetic people, which is surprising considering its relatively low population of 82 million. The global diabetes market was worth USD 27.3 billion in 2008 and was led by insulin analogs which captured 45.0% of the market followed by glitazones with share of 22.8%. The United States is the largest global diabetes market with sales of USD 12.9 billion in 2008, equaling 47.6% of the world market. Highest growth in sales can be found in several early emerging economies such as the UAE with a 59.7% growth rate . Germany for years has been thought of as trailing in diabetic research, and product development. The United States for example invests 50 dollars for every dollar invested in diabetes research/product development in Germany. This is evidenced by the amount of new products coming from the United States in the last few years. Germany is however trying to turn this trend around and is moving away from focusing on treating diseases after they occur and is turn